MONTREAL Many in the international science community reacted with disappointment and not a little frustration on Wednesday, after finally seeing statistical data from a study on the effectiveness of medication colchicine. “We can confirm that the primary outcome was not statistically significant,” said Dr. Emily McDonald a scientist at the MUHC’s Research Institute. The anti-inflammatory drug, now used to treat gout was touted by the Montreal Heart Institute just days ago in a press release, as an effective oral medication for non-hospitalized COVID-19 patients. In a Friday press release, the MHI researchers claimed the drug reduced the risk of death or hospitalization for COVID-19 by 21 per cent.
La colchicine n est pas le remède miracle vanté par des chercheurs montréalais
rcinet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rcinet.ca Daily Mail and Mail on Sunday newspapers.
So much more of the story we re missing : Quebec doctors urge caution on new study to treat the coronavirus with colchicine
montreal.ctvnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montreal.ctvnews.ca Daily Mail and Mail on Sunday newspapers.
A new study published January 15 in JAMA Internal Medicine, led by Drs. Todd Lee and Emily McDonald from the Research Institute of the McGill University Health Centre (RI-MUHC), confirms the efficiency of saliva testing for COVID-19. This follows a study published earlier in the week by another RI-MUHC team showing that saliva samples for COVID-19 testing are as good as nasopharyngeal swabs, but cheaper. These findings could rapidly influence global public health policy for testing strategies.
âPrevious studies on the performance of saliva tests showed mixed results, but most of them compared saliva tests to the standard nasal swab test, as if it was a perfect test. Interestingly, there are no perfect tests for COVID-19,â says Dr. Guillaume Butler-Laporte, first author of the study released today.